Clinical Trial Update: A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical pharmacology study of MT-2990 in seasonal allergic rhinitis has been completed, providing early pharmacokinetic and safety data in affected pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• MT-2990

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Seasonal Allergic Rhinitis | Phase 1 | Status: COMPLETED